USD 298.91 Million
Global Mycoplasma Testing Market Size, Share, Growth Analysis, By Application(Cell Line Testing, Virus Testing), By End-Use(Academic Research Institutes, Cell Banks) - Industry Forecast 2024-2031
Report ID:
SQMIG35I2219 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
66 |
Figures:
75
Global Mycoplasma Testing Market Insights
Global Mycoplasma Testing Market size was valued at USD 298.91 Million in 2022 and is poised to grow from USD 340.76 Million in 2023 to USD 972.04 Million by 2031, at a CAGR of 14% during the forecast period (2024-2031).
The purpose of the mycoplasma testing market is to provide reliable, accurate, and efficient tools and services for detecting and preventing Mycoplasma contamination in various settings. The market encompasses various types of products, including kits, reagents, instruments, and software, as well as laboratory services, such as testing, validation, and consulting. The mycoplasma testing market serves various industries, including biotechnology, pharmaceuticals, academic research, and clinical diagnostics.
The mycoplasma testing market is driven by several factors, including the growing demand for biopharmaceuticals and cell-based therapies, increasing awareness of the risks and consequences of mycoplasma contamination, and the emergence of advanced technologies and platforms for mycoplasma testing. In addition, the regulatory requirements and guidelines for mycoplasma testing have become more stringent and standardized, creating a need for more robust and efficient testing solutions. The mycoplasma testing market also faces several restraining factors, such as the high cost of testing products and services, the lack of standardization and harmonization of testing methods, and the limited availability of skilled personnel and infrastructure for mycoplasma testing. The mycoplasma testing market also faces several challenges, such as the need for continuous innovation and improvement of testing products and services to keep up with the evolving needs and demands of customers and regulators. The market also needs to address the issues of false-positive and false-negative results, cross-reactivity with other contaminants, and the potential for genetic variability and adaptation of mycoplasma strains. The mycoplasma testing market presents various opportunities for growth and expansion, such as the development of new testing technologies and platforms, the expansion of the market to new geographies and industries, and the integration of mycoplasma testing with other quality control and assurance systems. The market can leverage the growing trend of digitization and automation of laboratory workflows and data management to enhance the efficiency and accuracy of Mycoplasma testing.
US Mycoplasma Testing Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Cell Line Testing
Fastest Growth
Cell Line Testing
Growth Rate
14% CAGR
Global Mycoplasma Testing Market ($ Bn)
Country Share for North America Region (%)
Global Mycoplasma Testing Market Size By Application ($ Bn)
Global Mycoplasma Testing Market Size By Application (%)
To get more reports on the above market click here to Buy The Report
Global Mycoplasma Testing Market Segmental Analysis
The global mycoplasma testing market is segmented on the application, end-use and region. By application, the market is segmented into cell line testing, virus testing, end of production cells testing, others. By end-use, the market is segmented into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Mycoplasma Testing Market Analysis by Application
In 2022, the cell line testing segment accounted for the largest share of 42.3% as well as the fastest growth rate During the forecast period, owing to the increase in research projects being done in the field of cell culture. The Canadian Institutes of Health Research (CIHR), the country's official funding body for health research, has given roughly USD 981 million in assistance to numerous Canadian health researchers. Several Canadian life science enterprises, including small and medium-sized businesses engaged in product development and innovation, are receiving technical help from the National Research Council's Industrial Research and Assistance Programme (NRC-IRAP).
Cell culture is also predicted to see the biggest growth during the projection period due to an increase in mycoplasma contamination. Contamination with mycoplasma can result in the creation of toxins and modifications to the production of metabolites in cell culture. In the biopharmaceutical and pharmaceutical industries, cell line testing and authentication are accorded the utmost importance.
Mycoplasma Testing Market Analysis by End-use
In 2021, The pharmaceutical and biotechnology companies segment received the highest revenue shares of 36.2%, as well as the fastest CAGR throughout the forecast period. due to the substantial R&D investments made by these companies, which have facilitated improvements in the field of medication development research. To manage biological safety, these businesses conduct quality checks on raw materials. The prevalence of diseases like psoriasis and rheumatoid arthritis is increasing, which is fueling the expansion of the biopharmaceutical sector. Contract research organizations (CROs) are expected to increase profitably throughout the anticipated period due to the growing research services given by these companies. They require the use of mycoplasma tests, confirming the standard of the outsourced testing services, to guarantee the sterility of cultures used in preclinical research and biopharmaceutical development.
Global Mycoplasma Testing Market Size By Application, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Mycoplasma Testing Market Regional Insights
In 2022, North America dominated the market and accounted for a revenue share of 40.0%. Due to the well-established healthcare sector in this business and the increased prevalence of respiratory illnesses, market share growth is predicted. The existence of multinational pharmaceutical and biotech corporations in the area, as well as increased investment in R&D operations, are other factors contributing to the growth of this region.
Asia Pacific is estimated to see an exponential CAGR during the anticipated time period due to rising healthcare expenses and the need for improved infrastructure for laboratory and clinical research. Additionally, it is anticipated that regulatory policies promoting improvements in biosafety quality would foster future growth potential in healthcare companies. The Indian government is putting various strategic initiatives into place to stimulate more research and innovation for the creation of new medications, which will spur market expansion.
Global Mycoplasma Testing Market Size By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Mycoplasma Testing Market Dynamics
Mycoplasma Testing Market Drivers
Increasing Demand for Biopharmaceuticals and Cell-based Therapies
- The growing demand for biopharmaceuticals and cell-based therapies is driving the Mycoplasma testing market. These products and therapies require high-quality cells that are free from Mycoplasma contamination to ensure their safety and efficacy.
Rising Awareness of the Risks and Consequences of Mycoplasma Contamination
- The awareness of the risks and consequences of Mycoplasma contamination increases, the demand for Mycoplasma testing is also rising. Mycoplasma contamination can compromise experimental results, alter the behavior of cells, and cause health hazards for researchers and patients.
Mycoplasma Testing Market Restraints
High Cost of Testing Products and Services
- The high cost of mycoplasma testing products and services can be a significant barrier for many customers, especially in emerging markets or low-resource settings. The cost of mycoplasma testing can vary depending on the type of test used, the complexity of the sample, and the sensitivity and specificity of the test. Some of the more advanced testing methods, such as PCR-based assays or high-throughput sequencing, can be particularly expensive, making them inaccessible to some customers.
Lack of Standardization and Harmonization of Testing Methods
- The lack of standardization and harmonization of Mycoplasma testing methods can lead to variability and inconsistency in the results, making it challenging to compare and interpret data across different laboratories and applications. There are currently no universally accepted standards for Mycoplasma testing, and different laboratories and manufacturers may use different methods, reagents, and protocols. This can lead to variability and inconsistency in the results, making it challenging to compare and interpret data across different laboratories and applications. In addition, the lack of standardization can make it difficult to assess the performance and reliability of different Mycoplasma testing products and services.
Request Free Customization of this report to help us to meet your business objectives.
Global Mycoplasma Testing Market Competitive Landscape
The nature of the global mycoplasma testing market is highly competitive owing to the presence of several established players and new entrants. The market players are focusing on developing advanced technologies and solutions, expanding their product portfolios, and establishing strategic partnerships and collaborations to strengthen their position in the market. The Mycoplasma testing market is expected to continue to grow and evolve, driven by technological advancements, increasing demand for biopharmaceuticals and cell-based therapies, and stringent regulatory requirements. The market players are likely to continue to invest in R&D and innovation to develop more efficient, accurate, and cost-effective testing solutions to meet the growing demand from customers.
Mycoplasma Testing Market Top Player’s Company Profiles
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (US)
- Lonza Group Ltd. (Switzerland)
- Sartorius AG (Germany)
- PromoCell GmbH (Germany)
- American Type Culture Collection (ATCC) (US)
- Agilent Technologies, Inc. (US)
- Bionique Testing Laboratories, Inc. (US)
- Biological Industries Israel Beit Haemek Ltd. (Israel)
- Charles River Laboratories International, Inc. (US)
- Creative Bioarray (US)
- InvivoGen (US)
- Minerva Biolabs GmbH (Germany)
- Biological Industries US, Inc. (US)
- Norgen Biotek Corp. (Canada)
- Novacyt Group (UK)
- Mycoplasma Experience (France)
- Genscript Biotech Corporation (China)
- GeneCopoeia, Inc. (US)
- Jena Bioscience GmbH (Germany)
Mycoplasma Testing Market Recent Developments
- In February 2024, the PPD clinical research business of Thermo Fisher Scientific Inc. added mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
- In December 2023, QIAGEN N.V. announced the launch of three new kits for use on its QIAcuity systems and a major new software update. The new QIAcuity Mycoplasma Quant Kit offers researchers an accurate and precise way to detect mycoplasma contaminants in all steps of research and manufacturing of cell and gene therapies.
- In December 2021, Asahi Kasei Medical Co., Ltd. announced that it has (via a wholly owned subsidiary) fully acquired Bionique Testing Laboratories LLC (Bionique), a leader in mycoplasma testing services for the biotherapeutics and life-sciences industries.
Global Mycoplasma Testing Key Market Trends
- Development of advanced testing technologies and platforms: The Mycoplasma testing market is witnessing the development of advanced technologies and platforms, such as PCR-based assays, nucleic acid sequencing, and flow cytometry, that offer higher sensitivity, specificity, and speed compared to traditional culture-based methods.
- Integration of Mycoplasma testing with other quality control and assurance systems: The integration of Mycoplasma testing with other quality control and assurance systems, such as microbial identification, endotoxin testing, and bioburden testing, is becoming more prevalent in the Mycoplasma testing market. This trend allows customers to streamline their workflows and reduce the turnaround time and cost of testing.
Global Mycoplasma Testing Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global mycoplasma testing market analyses, the increasing incidence of mycoplasma contamination in cell cultures, the growing demand for biopharmaceuticals, and the increasing focus on quality control in the biotechnology and pharmaceutical industries. The primary factors driving the market is the increasing incidence of mycoplasma contamination in cell cultures. Mycoplasma contamination is a common problem in cell culture-based research and manufacturing, with studies estimating that up to 36% of cell lines used in research may be contaminated with mycoplasma. This can result in significant negative effects on experimental results and product quality, leading to increased demand for mycoplasma testing solutions. Another factor driving the market is the growing demand for biopharmaceuticals. Biopharmaceuticals, such as monoclonal antibodies and recombinant proteins, are an increasingly important segment of the pharmaceutical industry. However, biopharmaceutical production often involves the use of cell cultures, which are susceptible to Mycoplasma contamination. This has led to increased demand for Mycoplasma testing solutions to ensure the safety and efficacy of biopharmaceutical products.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 298.91 Million |
| Market size value in 2031 | USD 972.04 Million |
| Growth Rate | 14% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Mycoplasma Testing Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Mycoplasma Testing Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Mycoplasma Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Mycoplasma Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Mycoplasma Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Mycoplasma Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Mycoplasma Testing Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 617-230-0741
